A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
第一作者:
H,Link
第一单位:
Department of Hematology and Oncology, Medizinische Hochschule Hannover, Germany.
作者:
主题词
成年人(Adult);抗肿瘤药(Antineoplastic Agents);细菌感染(Bacterial Infections);输血(Blood Transfusion);骨髓净化(Bone Marrow Purging);骨髓移植(Bone Marrow Transplantation);综合疗法(Combined Modality Therapy);双盲法(Double-Blind Method);女(雌)性(Female);粒细胞巨噬细胞集落刺激因子(Granulocyte-Macrophage Colony-Stimulating Factor);人类(Humans);白细胞计数(Leukocyte Count);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);多元分析(Multivariate Analysis);病人隔离(Patient Isolation);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);概率(Probability);预后(Prognosis);重组蛋白质类(Recombinant Proteins);存活率分析(Survival Analysis);时间因素(Time Factors);移植, 自体(Transplantation, Autologous);全身照射(Whole-Body Irradiation)
PMID
1421390
发布时间
2021-02-16
- 浏览14

Blood
2188-95页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文